G. Kahn

Director/Board Member at SOLID BIOSCIENCES INC.

Net worth: 21 726 $ as of 2026-05-30

74 year

Health Technology

Consumer Services

Profile

G.
Clare Kahn is currently President at Clare Kahn Pharma Consulting LLC since 2016.
Independent Director at Solid Biosciences, Inc. since 2021.
Independent Director at Stoke Therapeutics, Inc. starting in 2026.
Formerly Vice President-Global Innovative Pharma at Pfizer Inc. from 2014 to 2016.
Vice President-Regulatory Affairs at GSK Plc from 1999 to 2010.
Chief Regulatory & Preclinical Development Officer at X-Vax Technology, Inc. from 2018 to 2019.
Assistant Professor at the University of Pennsylvania from 1981 to 1985.
Earned a doctorate from Royal Postgraduate Medical School in 1981.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SOLID BIOSCIENCES INC. 0%	2026-06-09	2,960 ( 0% )	21 726 $	2026-05-30

G. Kahn active positions

Companies	Position	Start
SOLID BIOSCIENCES INC.	Director/Board Member	2021-03-01
STOKE THERAPEUTICS, INC.	Director/Board Member	2026-04-02
Clare Kahn Pharma Consulting LLC	President	2016-05-31

All active positions of G. Kahn

Former positions of G. Kahn

Companies	Position	End
PFIZER INC.	Corporate Officer/Principal	2016-05-31
GSK PLC	General Counsel	2009-12-31
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	1984-12-31
X-Vax Technology, Inc. X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products	Chief Tech/Sci/R&D Officer	-

See the detail of G. Kahn's experience

Training of G. Kahn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of G. Kahn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Solid Biosciences, Inc. Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease	Health Technology
X-Vax Technology, Inc. X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products	Health Technology
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases	Health Technology
Royal Postgraduate Medical School Royal Postgraduate Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Clare Kahn Pharma Consulting LLC